Boardroom Alpha
Boardroom Alpha
CNK · Current Report (Form 8-K) · Filed August 18, 2025

Cinemark Holdings Inc — Current Report (Form 8-K)

Form
8-K
Filed
August 18, 2025
Period
Aug 15, 2025
Ticker
CNK
Accession
0000950157-25-000684
Boardroom Alpha · Filing insights

Cinemark to unwind warrants tied to its 2025 notes; settlement 50% cash and 50% stock based on VWAP during Aug 18–Nov 3, 2025.

About Cinemark Holdings Inc
Market cap
$3.6B
1Y TSR
−13.2%
3Y TSR
+17.7%
Board grade
B-
Sector
Communication Services
CEO
Sean Gamble
Last annual meeting: May 14, 2026 · View full Cinemark Holdings Inc profile →


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549



FORM 8-K



CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): August 15, 2025



CINEMARK HOLDINGS, INC.
(Exact name of registrant as specified in its charter)



Delaware
 
001-33401
 
20-5490327
(State or other jurisdiction
 
(Commission
 
(I.R.S. Employer
of incorporation)
 
File Number)
 
Identification No.)

3900 Dallas Parkway, Plano, Texas
 
75093
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: 914-701-8000

Not Applicable

Former name or former address, if changed since last report



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, par value $0.001 per share
 
CNK
 
The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






Item 1.01 Entry into a Material Definitive Agreement.

In connection with the pricing of the Cinemark Holdings, Inc’s (the “Company”) 4.50% Convertible Senior Notes due 2025 (the “Notes”), on August 18, 2020, and in connection with the exercise by the initial purchasers of their option to purchase additional Notes on August 20, 2020, the Company entered into privately negotiated warrant transactions with one or more of the initial purchasers of the Notes or their respective affiliates (the “Counterparties”), individually, whereby it sold to the Counterparties warrants to purchase (subject to the net share settlement provisions set forth therein) shares of the Company’s common stock (“common stock”) up to the number of shares underlying the aggregate amount of the Notes, subject to customary anti-dilution adjustments (collectively, the “Warrant Transactions”).

On August 15, 2025 the Company entered into individual warrant unwind and termination agreements with the Counterparties relating to the Warrant Transactions (collectively, the “Warrant Early Termination Agreements”). Pursuant to the Warrant Early Termination Agreements, the Company will deliver to each Counterparty, based on a 55 trading day observation period commencing on and including August 18, 2025 and ending on November 3, 2025, total consideration consisting of 50% cash and 50% common stock, the amount of which will be determined based upon the volume-weighted average price per share of the Company’s common stock during the observation period as specified in the Warrant Early Termination Agreements.  The Warrant Early Termination Agreements will settle either on a weekly basis during the observation period or, in other cases, two business days after the expiration of the observation period.

The foregoing description of the Warrant Early Termination Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of each Warrant Early Termination Agreement, forms of which are filed with this Current Report on Form 8-K as Exhibit 10.1 and which is incorporated herein by reference.

(d)           Exhibits.

Exhibit Number
 
Description of Exhibit
     

104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CINEMARK HOLDINGS, INC.
 
By:
 /s/ Michael D. Cavalier
 
Name:
Michael D. Cavalier
 
Title:
Executive Vice President – General Counsel and Business Affairs & Secretary
     


Date: August 18, 2025

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Cinemark Holdings Inc (CNK)

Reference

Frequently asked questions

When did Cinemark Holdings Inc file this 8-K?
Cinemark Holdings Inc (CNK) filed this Current Report (Form 8-K) with the SEC on August 18, 2025. The accession number assigned by EDGAR is 0000950157-25-000684.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Cinemark to unwind warrants tied to its 2025 notes; settlement 50% cash and 50% stock based on VWAP during Aug 18–Nov 3, 2025. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Cinemark Holdings Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Cinemark Holdings Inc has filed under CIK 1385280, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer